Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations.

Autor:	Nguyen HH; Institute of Genome Research, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam., Nguyen HTT; Institute of Genome Research, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam., Vu NP; Institute of Genome Research, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam., Le QT; National Institute of Ophthalmology, Hanoi, Vietnam., Pham CM; National Institute of Ophthalmology, Hanoi, Vietnam., Huyen TT; Institute of Genome Research, Vietnam Academy of Science and Technology., Manh H; Institute of Genome Research, Vietnam Academy of Science and Technology., Pham HLB; Institute of Genome Research, Vietnam Academy of Science and Technology., Nguyen TD; Institute of Genome Research, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam., Le HTT; Institute of Genome Research, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam., Van Nong H; Institute of Genome Research, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Jazyk:	angličtina
Zdroj:	Molecular vision [Mol Vis] 2018 Mar 17; Vol. 24, pp. 231-238. Date of Electronic Publication: 2018 Mar 17 (Print Publication: 2018).
Abstrakt:	Purpose: Retinoblastoma (Rb) is a rare and unique eye cancer that usually develops in the retinas of children less than 5 years old due to mutations in the RB1 gene. About 40% of affected individuals have the heritable form making genetics testing of the RB1 gene important for disease management. This study aims to identify germline mutations in RB1 in a cohort of patients with Rb from northern Vietnam. Methods: Genomic DNA was extracted from peripheral blood of 34 patients with Rb (nine unilateral and 25 bilateral cases) and their available parents. Twenty-seven exons, flanking sequences, and the promoter region of RB1 gene were screened for mutations with direct PCR sequencing. Multiplex ligation-dependent probe amplification (MLPA) was applied for patients with negative sequencing results. In the mutation-positive patients, their available parental DNA was analyzed to determine the parental origin of the mutation. Results: Germline mutations in RB1 were identified in 25 (73.53%) of 34 patients (four unilateral and 21 bilateral cases). Of these mutations, 19 were detected, including seven nonsense, six frameshift, four splice-site (one was identified in two siblings), and one missense, with Sanger sequencing. Three novel frameshift mutations were discovered in one unilateral and two bilateral patients. MLPA detected mutations in the RB1 gene in six bilateral cases, of whom five had a whole gene deletion (three familial cases) and one had a partial gene deletion (from exon 4 to exon 27) in one allele of the RB1 gene. Parental testing showed five mutations originated from the fathers and one was inherited from a mother who was mosaic for the mutation. Conclusions: This study provides a data set of germline mutations in the RB1 gene in Vietnamese patients with retinoblastoma. Screening of mutations in the RB1 gene can help to identify heritable Rb and contribute to clinical management and genetic counseling for affected families.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu